ranking,issue,percentage who rated it in top 3 issues
1,Who should be the primary decision makers about synthetic biology policy,68.00%
2,Ethical frameworks for and issues relating to safety and control,59.00%
3,Transparency and monitoring of technologies,50.00%
4,Need for education and public understanding of synthetic biology,38.00%
5,Risk/benefit analyses,26.00%
6,"Practicality of regulations recognizing potentials, certainties, and boundaries",23.00%
7,Concerns about benefits from commercialization and IP laws,14.00%
8,Need for a systemic/holistic view,13.00%
9,Funding mechanisms (public versus private returns),10.00%
